| Structure | Chemical Name | CAS | MF |
|
BOC-L-TYR(ALL)-OH
|
127132-38-1
|
C17H23NO5
|
|
N-(trifluoroacetyl)valyl-O'-(2,3-epoxypropyl)tyrosyl-valine methyl ester
|
127132-43-8
|
C25H34F3N3O7
|
|
Quaternary ammonium compounds, diethylmethyl(.gamma.-.omega.-perfluoro-C8-14-.beta.-alkenyl), Me sulfates
|
127133-57-7
|
|
|
|
C21-38 alkanes, chlorinated-, (chlorinated paraffin)
|
127133-59-9
|
|
|
2-Propenoic acid, 2-methyl-, C11-16-branched and linear alkyl esters, telomers with Bu acrylate, 1-dodecanethiol and 2-methyl-2-propenenitrile, tert-Bu octaneperoxoate-initiated
|
127133-64-6
|
C39H73NO7S
|
|
4(1H)-Quinolinethione,6,7-dihydroxy-1-methyl-(9CI)
|
127133-92-0
|
C10H9NO2S
|
|
DABCYL-GAMMA-ABU-SER-GLN-ASN-TYR-PRO-ILE-VAL-GLN-EDANS
|
127134-13-8
|
C73H97N17O18S
|
|
gamma-tetrazole-aminopterin
|
127134-21-8
|
C19H20N12O3
|
|
Cyclopentanecarboxaldehyde, 3-hydroxy-2,3-dimethyl-, (1alpha,2beta,3alpha)- (9CI)
|
127135-65-3
|
C8H14O2
|
|
|
CP-47 protein
|
127137-94-4
|
|
|
|
complement cytolysis inhibitor
|
127138-17-4
|
|
|
FUZOPYZAZOL
|
127139-42-8
|
C12H19N3OS
|
|
2-Pyridinecarboxylicacid,4-ethoxy-,ethylester,1-oxide(9CI)
|
127140-62-9
|
C10H13NO4
|
|
Clarithromycin Impurity H
|
127140-69-6
|
C38H67NO14
|
|
4-Chlorobenzyl pinacolone
|
127141-86-0
|
C13H17ClO
|
|
compound 348U87
|
127142-14-7
|
C15H15ClN6S2
|
|
Benzene, 1-chloro-2-fluoro-3-isothiocyanato- (9CI)
|
127142-65-8
|
C7H3ClFNS
|
|
4-CHLORO-3-NITROPHENYL ISOTHIOCYANATE
|
127142-66-9
|
C7H3ClN2O2S
|
|
2,3,4-TRICHLOROPHENYL ISOTHIOCYANATE
|
127142-69-2
|
C7H2Cl3NS
|
|
1-ethyl-6-fluoro-7-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-4-oxoquinoline-3-carboxylic acid
|
127142-90-9
|
C21H26FN3O5
|
|
ETHYL 3-(BENZOYLAMINO)-2-OXO-6-PHENYL-2H-PYRAN-5-CARBOXYLATE
|
127143-18-4
|
C21H17NO5
|
|
1,1-di-(2-bromoethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide
|
127146-24-1
|
C7H13Br2ClN4O2
|
|
5,5,5-TRIFLUORO-3-OXO-PENTANOIC ACID ETHYL ESTER
|
127146-29-6
|
C7H9F3O3
|
|
Ethanamine, 2-(2-thiazolylthio)-
|
127152-00-5
|
C5H8N2S2
|
|
5-(4-BROMO-BENZYL)-2H-TETRAZOLE
|
127152-64-1
|
C8H7BrN4
|
|
|
Antimony oxide (Sb2O3), reaction products with talc
|
127153-81-5
|
|
|
Nitric acid, reaction products with cyclododecanol and cyclododecanone, by-products from, high-boiling fraction, Me esters
|
127153-83-7
|
C24H47NO5
|
|
N-(cyclopropylmethyl)-6,14-endo-etheno-7-(3-carboxy-3-n-butenyl)tetrahydronororipavine gamma-lactone
|
127154-03-4
|
C28H31NO5
|
|
1,3-Benzenedicarboxylic acid, polymer with decanedioic acid, dimethyl 1,4-benzenedicarboxylate, 2,2-dimethyl-1,3-propanediol, 1,2-ethanediol and 2,2-oxybisethanol
|
127155-15-1
|
C39H62O19
|
|
3-O-De(2,6-dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)-8,9,10,11-tetradehydro-9-deoxo-11,12-dideoxy-9,12-epoxy-6-O-MethylerythroMycin
|
127157-35-1
|
C30H51NO8
|
|
1-methyl-1-(2-chloroethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide
|
127158-46-7
|
|
|
1,1-di-(2-chloroethyl)-4-nitroso-4-(2-chloroethyl)semicarbazide
|
127158-47-8
|
C7H13Cl3N4O2
|
|
Piperazine, 1-methyl-4-(6-methyl-2-pyridinyl)- (9CI)
|
127158-81-0
|
C11H17N3
|
|
sodium:2-fluorobenzenesulfinate
|
127159-66-4
|
C6H4FNaO2S
|
|
2-Methyl-2-propenoic acid methyl ester polymer with 1,4-butanediyl di-2-propenoate, butyl 2-propenoate, ethyl 2-propenoate and 2-propenyl 2-methyl-2-propenoate
|
127162-56-5
|
C34H52O12
|
|
4-TRIFLUOROMETHYLBENZYLSULFONYL CHLORIDE
|
127162-96-3
|
C8H6ClF3O2S
|
|
2,2-Difluoro-1,3-benzodioxole-5-carbonyl chloride
|
127163-51-3
|
C8H3ClF2O3
|
|
(R)-(+)-8-METHOXY-2-AMINOTETRALIN
|
127165-18-8
|
C11H15NO
|
|
2-Benzyl-4-nitroisoindoline
|
127168-67-6
|
C15H14N2O2
|
|
2-Benzyl-5-nitroisoindoline
|
127168-68-7
|
C15H14N2O2
|
|
2-BENZYL-2,3-DIHYDRO-1H-ISOINDOL-5-YLAMINE
|
127168-70-1
|
C15H16N2
|
|
4-METHOXYISOINDOLINE
|
127168-73-4
|
C9H11NO
|
|
5-CHLOROISOINDOLINE HYDROCHLORIDE
|
127168-76-7
|
C8H8ClN
|
|
5-Chloro-2-[(4-methylphenyl)sulfonyl]isoindoline
|
127168-77-8
|
C15H14ClNO2S
|
|
4-Chloro-1H-pyrrolo[3,2-c]pyridine
|
127168-78-9
|
C8H8FN
|
|
3-Bromo-1H-isoindoline
|
127168-81-4
|
C8H8BrN
|
|
1-broMo-2,3-bis(broMoMethyl)benzene
|
127168-82-5
|
C8H7Br3
|
|
4-Bromo-2-tosylisoindoline ,97%
|
127168-83-6
|
C15H14BrNO2S
|
|
5-BROMOISOINDOLINE
|
127168-84-7
|
C8H8BrN
|
|
4-NITROISOINDOLINE
|
127168-86-9
|
C8H8N2O2
|
|
5-METHOXY-2,3-DIHYDRO-1H-ISOINDOLE
|
127168-88-1
|
C9H11NO
|
|
B90102
|
127168-89-2
|
C16H17NO
|
|
Methyl isoindoline-4-carboxylate hydrochloride
|
127168-90-5
|
C10H12ClNO2
|
|
Methyl 2,3-bis(broMoMethyl)benzoate
|
127168-91-6
|
C10H10Br2O2
|
|
METHYL 2-BENZYLISOINDOLINE-4-CARBOXYLATE
|
127168-92-7
|
C17H17NO2
|
|
METHYL ISOINDOLINE-5-CARBOXYLATE HYDROCHLORIDE
|
127168-93-8
|
C10H12ClNO2
|
|
Methyl 2-benzylisoindoline-5-carboxylate
|
127168-94-9
|
C17H17NO2
|
|
isoindolin-4-ylMethanol
|
127168-95-0
|
C9H11NO
|
|
ISOINDOLIN-5-YLMETHANOL
|
127168-98-3
|
C9H11NO
|
|
(2-BENZYLISOINDOLIN-4-YL)METHANAMINE
|
127169-00-0
|
C16H18N2
|
|
2-BENZYLISOINDOLINE-4-CARBOXYLICACID
|
127169-17-9
|
C16H15NO2
|
|
8-Fluoro-2-Tetralone
|
127169-82-8
|
C10H9FO
|
|
2-hydroxy-3-(3H-imidazol-4-ylmethyl)-N-methyl-benzamide hydrochloride
|
127170-74-5
|
C12H14ClN3O2
|
|
2-hydroxy-3-[1-(3H-imidazol-4-yl)ethyl]benzamide hydrochloride
|
127170-75-6
|
C12H14ClN3O2
|
|
2-Hydroxy-3-(1H-imidazol-5-ylmethyl)-6-methylbenzamide Hydrochloride
|
127170-87-0
|
C12H14ClN3O2
|
|
N-(4-hydroxy-4-pyridin-3-yl-pentyl)-N-methyl-nitrous amide
|
127171-58-8
|
C11H17N3O2
|
|
Tetramethylammonium phthalate
|
127171-87-3
|
C16H28N2O4
|
|
Chitohexaose Hexahydrochloride
|
127171-88-4
|
C36H69ClN6O25
|
|
Chitoheptaose Heptahydrochloride
|
127171-89-5
|
C42H80ClN7O29
|
|
Chitooctaose 8HCl
|
127171-90-8
|
C48H91ClN8O33
|
|
4-Chloro-2-Methylquinolin-8-aMine
|
127171-93-1
|
C10H9ClN2
|
|
1-(3,4-diMethoxyphenyl)-3-(diMethylaMino)prop-2-en-1-one
|
127172-22-9
|
C13H17NO3
|
|
K 259-3
|
127172-90-1
|
C22H20O7
|
|
TRIDECETH-4 CARBOXYLIC ACID
|
127174-97-4
|
C21H42O6
|
|
Methanesulfonic acid, trifluoro-, 2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)ethyl ester
|
127175-39-7
|
C11H8F3NO5S
|
|
Carbonic acid, C,C'-1,4-phenylene C,C'-bis(1,1-dimethylethyl) ester
|
127175-62-6
|
C16H22O6
|
|
1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, salt with 4,4-(3,3-dichloro1,1-biphenyl-4,4-diyl)bisazo(2-acetyl-1-oxo-2,1-ethanediyl)iminobisbenzenesulfonic acid (2:1)
|
127179-40-2
|
C70H104Cl2N7O10S2-
|
|
3',4-O-dimethylcedrusin
|
127179-41-3
|
C21H26O6
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxylic acid, 3-methyl-, (1S,2S,3R,4R)- (9CI)
|
127179-45-7
|
C9H12O2
|
|
1,2,3-Propanetriol, 1,2-diacetate, (S)-
|
127179-48-0
|
C7H12O5
|
|
4-O-DeMethylkadsurenin D
|
127179-70-8
|
C20H22O5
|
|
(S)-2-Chloro-3-phenylpropan-1-ol
|
127180-75-0
|
C9H11ClO
|
|
(1R,2S)-1-AMINO-2-(HYDROXYMETHYL)-CYCLOPROPANECARBOXYLIC ACID
|
127181-31-1
|
C5H9NO3
|
|
N-Desmethyl Clarithromycin (9E)-Oxime
|
127182-43-8
|
C37H68N2O13
|
|
ClarithroMycin IMpurity G
|
127182-44-9
|
C39H72N2O13
|
|
(3aS,6S)-7,7-Dichloro-4,5,6,7-tetrahydro-8,8-diMethyl-3H-3a,6-Methano-2,1-benzisothiazole 2,2-Dioxide
|
127184-04-7
|
C10H13Cl2NO2S
|
|
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
|
127184-05-8
|
C10H13Cl2NO3S
|
|
|
4-C10-13-SECALKYLDERIVATIVESBENZENESULFONICACID,SODIUMSALT
|
127184-52-5
|
|
|
|
Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, caprolactam-blocked
|
127184-53-6
|
|
|
|
comB protein
|
127187-58-0
|
|
|
|
ling zhi 8
|
127187-71-7
|
|
|
4-BOC-1-(6-METHYL-2-PYRIDYL)PIPERAZINE
|
127188-33-4
|
C15H23N3O2
|
|
Hydrazinecarboxamide, N-2-benzothiazolyl- (9CI)
|
127188-39-0
|
C8H8N4OS
|
|
7-(deoxyguanosin-N(2)-yl)aristolactam I
|
127191-85-9
|
C27H22N6O8
|
|
7-(deoxyadenosin-N(6)-yl)aristolactam I
|
127191-86-0
|
C27H22N6O7
|
|
KN-62
|
127191-97-3
|
C38H35N5O6S2
|
|
(Z)-3-hydroxy-1,3-bis(2-thienyl)-2-propen-1-one
|
127191-99-5
|
C11H8O2S2
|
|
2-(Cyanomethyl)-5,6-dichlorobenzimidazole
|
127192-16-9
|
C9H5Cl2N3
|
|
3-(4,6-Difluortriazinylamino)-7-methoxycoumarin
|
127192-67-0
|
C13H8F2N4O3
|
|
Ethanol, 2-(4-[2,2':6',2''-terpyridin]-4'-ylphenoxy)-
|
127192-72-7
|
C23H19N3O2
|